Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The apoptosis pathway in activated T-cells is a tightly regulated process essential for immune homeostasis. After an immune response, the majority of activated T-cells are eliminated via apoptosis to prevent excessive or prolonged immune activity and autoimmunity. This process involves both intrinsic (mitochondrial) and extrinsic (death receptor-mediated) pathways, with multiple molecular players orchestrating the decision between cell survival and programmed cell death. Key components include Bcl-2 family proteins (Bim, Puma, Bax, Bak, Bcl-2), cytochrome c, APAF1, caspases, Fas/FasL, TNFR1, TRAIL receptors, FADD, and TRADD. The pathway is triggered by cytokine withdrawal, persistent antigen stimulation (AICD), and cytotoxic T lymphocyte interactions. It functions to maintain immune balance and prevent autoimmunity. Pathway regulation is modulated by cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis Pathway in Activated T-Cells.